Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Saturday, June 29, 2019

Endovascular and hyper acute stroke management

I'm focusing on the line, neuroprotection fell out of favor. Would it have fallen out of favor if it was properly referred to as the neuronal cascade of death

Survivors in charge would never have let it fall out of favor. Will you all step aside and let survivors run this the proper way? Leading to 100% recovery.

Endovascular and hyper acute stroke management 

First Published June 18, 2019 Editorial
While advances in stroke generally continue to accelerate in terms of prevention, acute intervention, and recovery, the speed at which these changes are occurring is quite impressive. The introduction of thrombolysis as the first major acute intervention in acute ischemic stroke spreads at a fairly modest pace around the world, although it accelerated in later years as its efficacy became more clearly established with pooled analysis of existing trials and extension of the therapeutic stroke window out to 4.5 h. There was undoubtedly some reticence on the part of a smaller cohort of emergency physicians in some parts of the world to embrace thrombolysis as a stroke therapy, but this now has been dissipated by the tsunami of thrombectomy. The greater efficacy of thrombectomy with numbers needed to treat as low as 3 has led to its extraordinarily rapid uptake around the globe, particularly in the developed world. This was partly assisted by the health care systems, particularly involving stroke units, which provided fertile ground for the next therapeutic wave, certainly further adjustments in health care services have been required, and more work in this area needs to be done but not near the magnitude of change that was initially required after thrombolysis. Of course, change in low–middle income countries (LMICs) is taking a proportionately longer time to install these services.
A manifestation of the dynamics of these developments has been the changing emphasis of the longstanding 14th International Symposium on Thrombolysis, Thrombectomy and Acute Stroke Therapy: Proceedings and Summary of Discussions. This is usually held as a satellite to world stroke meetings since its inception. In earlier meetings, thrombolysis was the main focus, and then neuroprotection was added but later fell out of favor. The current meeting, held in Houston recently and reported in this edition, has a strong emphasis on thrombectomy and thrombolysis. It has been a driver of intellectual thought on acute therapy.
In keeping with our acute intervention theme, we also have a meta-analysis on glial fibrillary acidic protein as a biomarker for the presence of intracerebral hemorrhage. This represents one of a number of ongoing attempts to enable a distinction to be made between hemorrhagic and ischemic stroke, which will be of particular relevance in LMICs where imaging may not be readily available. Other attempts to improve pre-hospital diagnosis of stroke also appear in this edition with pre-hospital stroke scores to identify stroke mimics and also better algorithms for emergency service call centers.
Such energy focussed on the various aspects of stroke management throughout the continuum of care seems to be producing tangible benefits. We are delighted to be a vehicle to help bring this information to our global community.

No comments:

Post a Comment